Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification

– An Invitae-developed innovative approach to help reduce variants of uncertain significance – SAN FRANCISCO, March 12, 2024 /PRNewswire/ — Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks